Asthma and Respiratory Disorders News

NASHVILLE, Tenn. — Patients on biologic therapies for severe asthma or atopic dermatitis had lower pseudovirus neutralization 6 months after receiving the second dose of mRNA COVID-19 vaccines, according to a study presented at CHEST 2022.

Air pollution with smaller particulate matter had stronger associations with childhood asthma than pollution with larger particles, indicating that smaller particles may be more toxic, according to a study published in JAMA Network Open.

The addition of breathing exercises to usual care enhanced asthma-related quality of life in patients with incompletely controlled asthma, regardless of severity, without evidence of causing harm, according to study results.

Patients who used the Reliever Digihaler System had greater odds for better asthma control compared with patients who used standard inhalers, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

A noninvasive and validated symptom-based screening tool identified children who were at high risk for asthma as early as age 3 years, according to a study published in JAMA Network Open.

A dashboard revealed disparities that exist among patients with moderate to severe asthma who visited the ED, according to a study scheduled for presentation at the American Academy of Pediatrics National Conference & Exhibition.

People exposed to sensitizers and irritants on the job faced greater risks for current adult-onset asthma and uncontrolled asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Probiotic supplements such as Bifidobacterium infantis 35624 could improve asthma control and lung function while reducing the need to use rescue inhalers, according to a letter published in Annals of Allergy, Asthma & Immunology.

Healio compiled the most-read news in allergy, asthma and immunology posted in September.

Patients with severe asthma who are on subcutaneous immunotherapy for allergy treatment do not experience an increased risk for moderate to severe systemic reactions, according to a study published in Annals of Allergy, Asthma & Immunology.